Related Experiment Videos
[Captopril-induced eruptions: occurrence over a 3-year period]
Annales De Dermatologie Et De Venereologie
|January 1, 1983
Summary
This study analyzed dermatological side effects in 123 patients taking Captopril. Rashes occurred in 2.4% and pruritus in 10.5%, with findings compared to previous research on this angiotensin-converting enzyme inhibitor.
Area of Science:
- Pharmacology
- Dermatology
- Clinical Medicine
Background:
- Captopril is an angiotensin-converting enzyme (ACE) inhibitor commonly prescribed for hypertension.
- Dermatological adverse events are potential side effects of ACE inhibitor therapy.
- Understanding the frequency and characteristics of these symptoms is crucial for patient management.
Observation:
- A cohort of 123 patients treated with Captopril was analyzed for dermatological symptoms.
- The total treatment duration was 1,321 patient-months.
- Data on the incidence of specific skin reactions, including pruritus and rashes, were collected.
Findings:
- Pruritus was observed in 10.5% of patients treated with Captopril.
- Rashes were reported in 2.4% of the patient cohort.
- The reported frequencies were compared with existing literature, noting variations potentially linked to drug dosage.
Implications:
- The findings provide updated data on the prevalence of Captopril-induced dermatological side effects.
- Understanding these adverse events aids clinicians in risk assessment and patient counseling.
- Further research into the mechanisms underlying Captopril-associated rashes and pruritus is warranted.